Anti-UGT2B17 antibodies are used in the immunodetection of the protein UDP glucuronosyltransferase family 2 member B17. In humans, the canonical protein has a reported length of 530 amino acid residues and a mass of 61.1 kDa. Its subcellular localization is in the ER. It is reported to be expressed in various tissues including the liver, kidney, testis, uterus, placenta, mammary gland, adrenal gland, skin and prostate. A member of the UDP-glycosyltransferase protein family, UGT2B17 is reported to be a UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile. Synonyms for this target antigen include UDPGT2B17, UDP-glucuronosyltransferase 2B17, C19-steroid-specific UDP-glucuronosyltransferase, C19-steroid-specific UDPGT, and BMND12. Some UGT2B17 antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.